The U.S. Food and Drug Administration (FDA) issued a press release warning consumers about the dietary supplement, Venom HYPERDRIVE 3.0. Apparently, this dietary supplement contains sibutramine, which is a controlled substance with risks for abuse or addiction and is considered a potent drug that poses potential safety risks to those who take it.
“Sibutramine is the active ingredient in an FDA-approved prescription drug used as an appetite suppressant for weight loss. But when present in a dietary supplement, it may harm unsuspecting consumers because sibutramine can substantially increase blood pressure and heart rate (pulse), and may present a significant risk for people with a history of heart disease, heart failure, irregular heart beats or stroke,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research.
Applied Lifescience Research Industries Inc. (ALR Industries) has been marketing Venom HYPERDRIVE 3.0. The Oak View, California company initiated a recall of all lots of this dietary supplement after the FDA laboratory analysis found samples of the product contained undeclared sibutramine. ALR Industries posted on its website that there were only “trace amounts” of sibutramine found in Venom HYPERDRIVE 3.0, but the FDA tests showed that the dietary supplement had a significant amount of sibutramine per dosage unit.
This dietary supplement was sold throughout the country through distributors and retail stores. It was also sold in Canada, Poland, Sweden, Hungary, South Africa, the Netherlands, Australia, France and the United Kingdom. Venom HYPERDRIVE 3.0 was packaged in red plastic bottles that had 90 capsules each with the UPC# 094922534743.
The FDA has urged consumers to stop taking this product immediately and contact their health care provider if they have experienced any adverse side effects. Consumers can also contact ALR Industries at legal@alrindustries.com to receive additional information for returning the product and to ask any questions.
